109604-76-4Relevant academic research and scientific papers
A catalytic oxidation fragrant boron class compound preparing phenol method (by machine translation)
-
Paragraph 0027; 0061; 0062, (2017/08/08)
The invention discloses a method for catalytic oxidation of phenolic compounds fragrant boron class compound synthesis method, the flux in the solvent in the aqueous solution, under the action of alkali, adding hydrazine hydrate or acid hydrazides catalyst, catalytic oxidation fragrant boron class compound directly for the preparation of phenolic compound. The invention of the method of preparation of the phenol compound, the catalyst is a cheap hydrazine hydrate or hydrazine compound, the oxidizing agent is atmospheric pressure of air or oxygen, the reaction does not need good and activeness metal catalyst, is extensive and stable substrate, substrate-sensitive functional group compatibility good and wide range of application. In the optimized under the reaction conditions, the yield of the target product separation up to 99%. (by machine translation)
Color Tuning of Efficient Electroluminescence in the Blue and Green Regions Using Heteroleptic Iridium Complexes with 2-Phenoxyoxazole Ancillary Ligands
Benjamin, Helen,Liang, Jie,Liu, Yu,Geng, Yun,Liu, Xingman,Zhu, Dongxia,Batsanov, Andrei S.,Bryce, Martin R.
, p. 1810 - 1821 (2017/05/15)
A rational molecular design strategy for tuning the emission color of phosphorescent complexes by functionalization of the bis(2-phenylpyridine)(2-(2′-oxyphenyl)-2-oxazoline/oxazole)iridium(III) framework is reported. Five new complexes (2-6) have been synthesized in good yields and characterized by cyclic voltammetry, absorption, and photoluminescence studies, by time-dependent density functional theory (TD-DFT) calculations, and by single-crystal X-ray diffraction studies for complexes 2, 4, and 6. An interesting feature of the complexes is that the HOMO is localized on the Ir d-orbitals and the phenoxylate part of the “ancillary” ligand, while the LUMO is located on the pyridyl ring of the ppy ligands. A few other complexes containing 2′-oxyphenyl-2-oxazoline/oxazole ancillary ligands have been reported previously; however, until now there has not been a systematic investigation into manipulating this unusual frontier orbital distribution to tune the emissive properties. It is shown that exchanging the phenylpyridine (ppy) ligand for 2,4-difluoro-ppy gives a blue shift of 21-22 nm (from 1 to 2 and from 4 to 5), and the introduction of electron-withdrawing substituents (SO2Me, CF3) onto the phenoxylate ring of the (2′-oxyphenyl)-2-oxazole ligand results in a further blue shift of 13-20 nm. Combining these functionalizations gives sky-blue emission with λmaxPL 476 and 479 nm for complexes 5 and 6 in dichloromethane solution. The solution quantum yields of all the complexes are within the range ΦPL 0.42-0.73. The observed lifetimes (τobs = 1.52-3.01 μs) and spectral profiles are indicative of phosphorescence from a mixture of ligand-centered and MLCT excited states. (TD-)DFT calculations are in close agreement with the observed photophysical and electrochemical properties of the complexes. Phosphorescent organic light-emitting diodes have been fabricated using complexes 2, 3, 5, and 6 as the emitter, doped in a 4,4′-bis(N-carbazolyl)biphenyl host, giving efficient emission in the blue-green region. Notably, complex 5 gives λmaxEL 480 nm with a maximum brightness of 26150 cd m-2.
Compounds enhancing antitumor activity of other cytotoxic agents
-
, (2008/06/13)
This invention relates to certain heterocyclic compounds and their pharmaceutically acceptable salts, which are useful for sensitizing multidrug-resistant tumor cells to anticancer agents and multidrug resistant forms of malaria, tuberculosis, leishmania and amoebic dysentery to chemotherapeutants. The compounds and their pharmaceutically acceptable salts are also inhibitors of the active drug transport capability of P-glycoprotein which is encoded by the human MDR1 gene, as well as of certain other related ATP-binding-cassette transporters from eukaryotic and prokaryotic organisms (e.g., pfmdr from Plasmodium falciprum, and murine mdr1 and mdr3 gene products).
